CHRYSANTHEMUM

OTHER NAME(S):

Anthemis grandiflorum, Anthemis stipulacea, Chrysanth&egrave;me, Chrysanth&egrave;me des Jardins, Chrysanthemum indicum, Chrysanthemum sinense, Chrysanthemum stipulaceum, Chrysanthemum morifolium, Crisantemo, Dendranthema grandiflorum, Dendranthema morifolium, Fleur d’Or, Florist's Chrysanthemum, Flos Chrysantemi, Ju Hua, Matricaria morifolia, Mum, Yao Jiu Ha, Ye Ju Hua.<br/><br/>

Overview

Overview Information

Chrysanthemum (mum) is a plant. It gets its name from the Greek words for “gold” and “flower.” People use the flowers to make medicine.

Chrysanthemum is used to treat chest pain (angina), high blood pressure, type 2 diabetes, fever, cold, headache, dizziness, and swelling.

In combination with other herbs, chrysanthemum is also used to treat prostate cancer.

As a beverage, chrysanthemum is very popular as a summertime tea in southern China.

How does it work?

Chrysanthemum may increase blood flow to the heart. It may also increase sensitivity to insulin.

Uses

Uses & Effectiveness?

Insufficient Evidence for

More evidence is needed to rate the effectiveness of chrysanthemum for these uses.

Side Effects

Side Effects & Safety

There isn't enough information to know if chrysanthemum is safe. Chrysanthemum can cause skin to become extra sensitive to the sun. Wear sunblock outside, especially if you are light-skinned.

Special Precautions & Warnings:

Pregnancy and breast-feeding: There is not enough reliable information about the safety of taking chrysanthemum if you are pregnant or breast-feeding. Stay on the safe side and avoid use.

Plant allergies: Chrysanthemum is a member of the Asteraceae/Compositae family of plants and may cause an allergic reaction in people sensitive to other plants from this family. Other members of this family include ragweed, marigolds, daisies, and many others. If you have allergies, be sure to check with your healthcare provider before taking chrysanthemum.

Interactions

Interactions?

We currently have no information for CHRYSANTHEMUM Interactions.

Dosing

Dosing

The appropriate dose of chrysanthemum depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for chrysanthemum. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

  • Aberer, W. and Jarisch, R. [Chrysanthemum allergy]. Wien.Klin.Wochenschr. 6-26-1987;99(13):466-468. View abstract.
  • Alantolactone in chrysanthemum extract. Contact Dermatitis 1978;4(6):368-369. View abstract.
  • Burry, J. N. Compositae dermatitis in South Australia: contact dermatitis from Chrysanthemum parthenium. Contact Dermatitis 1980;6(6):445. View abstract.
  • Chen, K., Plumb, G. W., Bennett, R. N., and Bao, Y. Antioxidant activities of extracts from five anti-viral medicinal plants. J Ethnopharmacol 1-4-2005;96(1-2):201-205. View abstract.
  • Chen, S. H., Sun, Y. P., and Chen, X. S. [Effect of jiangtangkang on blood glucose, sensitivity of insulin and blood viscosity in non-insulin dependent diabetes mellitus]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1997;17(11):666-668. View abstract.
  • Diener, C., Schlenvoigt, G., Jager, L., Prater, E., and Schubert, H. Allergens of chrysanthemum pollen. Allergol.Immunopathol.(Madr.) 1986;14(1):49-53. View abstract.
  • Fischer, T. W., Bauer, A., Hipler, U. C., and Elsner, P. Non-immunologic contact urticaria from chrysanthemum confirmed by the CAST method. Complement-activated (C5a) cellular antigen stimulation test. Contact Dermatitis 1999;41(5):293-295. View abstract.
  • Frain-Bell, W., Hetherington, A., and Johnson, B. E. Contact allergic sensitivity to chrysanthemum and the photosensitivity dermatitis and actinic reticuloid syndrome. Br.J.Dermatol. 1979;101(5):491-501. View abstract.
  • Groenewoud, G. C., de Groot, H., and van Wijk, R. G. Impact of occupational and inhalant allergy on rhinitis-specific quality of life in employees of bell pepper greenhouses in the Netherlands. Ann Allergy Asthma Immunol 2006;96(1):92-97. View abstract.
  • Groenewoud, G. C., de Jong, N. W., Burdorf, A., de Groot, H., and van Wyk, R. G. Prevalence of occupational allergy to Chrysanthemum pollen in greenhouses in the Netherlands. Allergy 2002;57(9):835-840. View abstract.
  • Gromek, D., Kisiel, W., Stojakowska, A., and Kohlmunzer, S. Attempts of chemical standardizing of Chrysanthemum parthenium as a prospective antimigraine drug. Pol.J.Pharmacol.Pharm. 1991;43(3):213-217. View abstract.
  • Hashimoto, Y., Kawada, A., Aragane, Y., and Tezuka, T. Occupational contact dermatitis from chrysanthemum in a mortician. Contact Dermatitis 2003;49(2):106-107. View abstract.
  • Hausen, B. M. [Occupational contact allergy to feverfew Tanacetum parthenium (L.) Schultz-Bip.; Asteraceae]. Derm.Beruf.Umwelt. 1981;29(1):18-21. View abstract.
  • Hausen, B. M. and Oestmann, G. [The incidence of occupationally-induced allergic skin diseases in a large flower market]. Derm.Beruf.Umwelt. 1988;36(4):117-124. View abstract.
  • Hausen, B. M. and Schulz, K. H. [Chrysanthemum allergy. 1]. Berufsdermatosen. 1973;21(5):199-214. View abstract.
  • Hausen, B. M. and Schulz, K. H. [Polyvalent contact allergy in a florist]. Derm.Beruf.Umwelt. 1978;26(5):175-176. View abstract.
  • Hu, C. Q., Chen, K., Shi, Q., Kilkuskie, R. E., Cheng, Y. C., and Lee, K. H. Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids. J.Nat.Prod. 1994;57(1):42-51. View abstract.
  • Huang, C. J. and Wu, M. C. Differential effects of foods traditionally regarded as 'heating' and 'cooling' on prostaglandin E(2) production by a macrophage cell line. J Biomed Sci 2002;9(6 Pt 2):596-606. View abstract.
  • Jovanovic, M. and Poljacki, M. [Compositae dermatitis]. Med Pregl. 2003;56(1-2):43-49. View abstract.
  • Khallouki, F., Hmamouchi, M., Younos, C., Soulimani, R., and Essassi, E. M. A new flavonoid from the aerial parts of Chrysanthemum viscidehirtum. Fitoterapia 2000;71(4):413-416. View abstract.
  • Khallouki, F., Hmamouchi, M., Younos, C., Soulimani, R., Bessiere, J. M., and Essassi, E. M. Antibacterial and molluscicidal activities of the essential oil of Chrysanthemum viscidehirtum. Fitoterapia 2000;71(5):544-546. View abstract.
  • Kim, H. J. and Lee, Y. S. Identification of new dicaffeoylquinic acids from Chrysanthemum morifolium and their antioxidant activities. Planta Med 2005;71(9):871-876. View abstract.
  • Kim, K. J., Kim, Y. H., Yu, H. H., Jeong, S. I., Cha, J. D., Kil, B. S., and You, Y. O. Antibacterial activity and chemical composition of essential oil of Chrysanthemum boreale. Planta Med 2003;69(3):274-277. View abstract.
  • Kuno, Y., Kawabe, Y., and Sakakibara, S. Allergic contact dermatitis associated with photosensitivity, from alantolactone in a chrysanthemum farmer. Contact Dermatitis 1999;40(4):224-225. View abstract.
  • Kuroume, T., Todokoro, M., Tomidokoro, H., Kanbe, Y., and Matsumura, T. Chrysanthemum pollinosis in Japan. Int.Arch.Allergy Appl.Immunol. 1975;48(6):800-811. View abstract.
  • Lee, J. R., Yang, M. S., Jang, D. S., Ha, T. J., Park, K. M., Lee, C. H., Kho, Y. H., and Park, K. H. A new guaianolide as apoptosis inhibitor from Chrysanthemum boreale. Planta Med. 2001;67(6):585-587. View abstract.
  • Lee, J. R., Yang, M. S., Lee, J., Hwang, S. W., Kho, Y. H., and Park, K. H. New guaianolides from leaves and stems of Chrysanthemum boreale. Planta Med. 2003;69(9):880-882. View abstract.
  • Lee, J. S., Kim, H. J., and Lee, Y. S. A new anti-HIV flavonoid glucuronide from Chrysanthemum morifolium. Planta Med. 2003;69(9):859-861. View abstract.
  • Li, L. P. and Jiang, H. D. Determination and assay validation of luteolin and apigenin in human urine after oral administration of tablet of Chrysanthemum morifolium extract by HPLC. J Pharm Biomed Anal. 4-11-2006;41(1):261-265. View abstract.
  • Losche, W., Michel, E., Heptinstall, S., Krause, S., Groenewegen, W. A., Pescarmona, G. P., and Thielmann, K. Inhibition of the behaviour of human polynuclear leukocytes by an extract of Chrysanthemum parthenium. Planta Med. 1988;54(5):381-384. View abstract.
  • Macan, J., Varnai, V. M., and Turk, R. [Health effects of pyrethrins and pyrethroids]. Arh.Hig.Rada Toksikol. 2006;57(2):237-243. View abstract.
  • Mitchell, J. C., Dupuis, G., and Towers, G. H. Allergic contact dermatitis from pyrethrum (Chrysanthemum spp.). The roles of pyrethrosin, a sesquiterpene lactone, and of pyrethrin II. Br.J.Dermatol. 1972;86(6):568-573. View abstract.
  • Mitchell, J. C., Geissman, T. A., Dupuis, G., and Towers, G. H. Allergic contact dermatitis caused by Artemisia and Chrysanthemum species. The role of sesquiterpene lactones. J.Invest Dermatol. 1971;56(2):98-101. View abstract.
  • Paulsen, E., Andersen, K. E., and Hausen, B. M. Sensitization and cross-reaction patterns in Danish Compositae-allergic patients. Contact Dermatitis 2001;45(4):197-204. View abstract.
  • Proudfoot, A. T. Poisoning due to pyrethrins. Toxicol Rev 2005;24(2):107-113. View abstract.
  • Schmidt, R. J. and Kingston, T. Chrysanthemum dermatitis in South Wales; diagnosis by patch testing with feverfew (Tanacetum parthenium) extract. Contact Dermatitis 1985;13(2):120-121. View abstract.
  • Schmidt, R. J. When is a chrysanthemum dermatitis not a chrysanthemum dermatitis? The case for describing florists' chrysanthemums as Dendranthema cultivars. Contact Dermatitis 1985;13(2):115-119. View abstract.
  • Schmiedekampf, G., Schauder, S., and Berger, H. [Actinic reticuloid in a florist]. Derm.Beruf.Umwelt. 1978;26(3):95-96. View abstract.
  • Schubert, H., Prater, E., and Diener, C. [Pollinosis in chrysanthemum growers]. Z.Gesamte Hyg. 1990;36(3):162-163. View abstract.
  • Schulz, K. H., Hausen, B. M., Wallhofer, L., and Schmidt-Loffler, P. Chrysanthemum allergy. Pt. II: Experimental studies on the causative agents. Arch.Dermatol.Forsch. 1975;251(3):235-244. View abstract.
  • Sertoli, A., Campolmi, P., Fabbri, P., Gelsomini, N., and Panconesi, E. [Contact eczema caused by Chrysanthemum morifolium Ramat]. G.Ital.Dermatol.Venereol. 1985;120(5):365-370. View abstract.
  • Shahat, A. A., Apers, S., Pieters, L., and Vlietinck, A. J. Isolation and complete NMR assignment of the numbing principle from Chrysanthemum morifolium. Fitoterapia 2001;72(1):89-91. View abstract.
  • Sharma, S. C. and Kaur, S. Airborne contact dermatitis from Compositae plants in northern India. Contact Dermatitis 1989;21(1):1-5. View abstract.
  • Sharma, S. C., Tanwar, R. C., and Kaur, S. Contact dermatitis from chrysanthemums in India. Contact Dermatitis 1989;21(2):69-71. View abstract.
  • Singh, R. P., Agrawal, P., Yim, D., Agarwal, C., and Agarwal, R. Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate. Carcinogenesis 2005;26(4):845-854. View abstract.
  • Singhal, V. and Reddy, B. S. Common contact sensitizers in Delhi. J Dermatol 2000;27(7):440-445. View abstract.
  • Stanberry, L. R., Bernstein, D. I., and Myers, M. G. Evaluation of the herpes simplex virus antiviral activity of pyrethrins. Antiviral Res 1986;6(2):95-102. View abstract.
  • Sugai, T., Takahashi, Y., and Okuno, F. Chrysanthemum dermatitis in Japan. Contact Dermatitis 1980;6(2):155. View abstract.
  • Swierczyniska-Machura, D., Krakowiak, A., and Palczynski, C. [Occupational allergy caused by ornamental plants]. Med Pr 2006;57(4):359-364. View abstract.
  • Tanaka, T., Moriwaki, S. I., and Horio, T. Occupational dermatitis with simultaneous immediate and delayed allergy to chrysanthemum. Contact Dermatitis 1987;16(3):152-154. View abstract.
  • Ukiya, M., Akihisa, T., Tokuda, H., Suzuki, H., Mukainaka, T., Ichiishi, E., Yasukawa, K., Kasahara, Y., and Nishino, H. Constituents of Compositae plants III. Anti-tumor promoting effects and cytotoxic activity against human cancer cell lines of triterpene diols and triols from edible chrysanthemum flowers. Cancer Lett. 3-8-2002;177(1):7-12. View abstract.
  • Wakelin, S. H., Marren, P., Young, E., and Shaw, S. Compositae sensitivity and chronic hand dermatitis in a seven-year-old boy. Br J Dermatol 1997;137(2):289-291. View abstract.
  • Wang, H., Ye, X. Y., and Ng, T. B. Purification of chrysancorin, a novel antifungal protein with mitogenic activity from garland chrysanthemum seeds. Biol.Chem. 2001;382(6):947-951. View abstract.
  • Zeller, W., de Gols, M., and Hausen, B. M. The sensitizing capacity of Compositae plants. VI. Guinea pig sensitization experiments with ornamental plants and weeds using different methods. Arch Dermatol.Res 1985;277(1):28-35. View abstract.
  • Bleumink E, Mitchell JC, Geismann TA, Towers GH. Contact hypersensitivity to sesquiterpene lactones in Chrysanthemum dermatitis. Contact Dermatitis 1976;2:81-8. View abstract.
  • Camplimi P, Sertoli A, Fabbri P, Panconesi E. Alantolactone sensitivity in chrysanthemum contact dermatitis. Contact Dermatitis 1978;4:93-102. View abstract.
  • Chen SH, Yen YP, Chen XS. Effect of jiantangkang on blood glucose, sensitivity of insulin, and blood viscosity in non-insulin dependent diabetes mellitus. Chung Kuo Chung His I Chieh Ho Tsa Chih 1997;17:666-8.
  • deJong NW, Vermeulen AM, van Wijik RG, deGroot H. Occupational allergy caused by flowers. Allergy 1998;53:204-9. View abstract.
  • Hadis M, Lulu M, Mekonnen Y, Asfaw T. Field trials on the repellent activity of four plant products against mainly Mansonia population in western Ethiopia. Phytother Res 2003;17:202-5. View abstract.
  • Hausen BM. The sensitizing capacity of Compositae plants. III. Test results and cross-reactions in Compositae-sensitive patients. Dermatologica 1979;159:1-11. View abstract.
  • Huang KC. The Pharmacology of Chinese Herbs. 2nd ed. New York, NY: CRC Press, LLC 1999:113-114, 417.
  • Hussain Z, Waheed A, Qureshi RA, et al. The effect of medicinal plants of Islamabad and Murree region of Pakistan on insulin secretion from INS-1 cells. Phytother Res 2004;18:73-7. View abstract.
  • Jaspersen-Schib R, Theus L, Guirguis-Oeschger M, et al. [Serious plant poisonings in Switzerland 1966-1994. Case analysis from the Swiss Toxicology Information Center]. Schweiz Med Wochenschr 1996;126:1085-98. View abstract.
  • Kong LD, Cai Y, Huang WW, et al. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J Ethnopharmacol 2000;73:199-207. View abstract.
  • Kuno Y, Kawabe Y, Sakakibara S. Allergic contact dermatitis associated with photosensitivity, from alantolactone in a chrysanthemum farmer. Contact Dermatitis 1999;40:224-5.
  • Lamminpaa A, Estlander T, Jolanki R, Kanerva L. Occupational allergic contact dermatitis caused by decorative plants. Contact Dermatitis 1996;34:330-5. View abstract.
  • Paulsen E, Sogaard J, Andersen KE. Occupational dermatitis in Danish gardeners and greenhouse workers (III). Compositae-related symptoms. Contact Dermatitis 1998;38:140-6. View abstract.
  • Wang HK, Xia Y, Yang ZY, et al. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Adv Exp Med Biol 1998;439:191-225. View abstract.
  • Yu XY. [A prospective clinical study on reversion of 200 precancerous patients with hua-sheng-ping]. Chung Kuo Chung His I Chieh Ho Tsa Chih 1993;13:147-9. View abstract.

More Resources for CHRYSANTHEMUM

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2018.